Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard I Fisher

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Seminars in Oncology|May 3, 2003
Overview of non-Hodgkin's lymphoma: biology, staging, and treatmentRichard I Fisher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Autologous stem-cell transplantation as a component of initial treatment for poor-risk patients with aggressive non-Hodgkin's lymphoma: resolved issues versus remaining opportunityRichard I Fisher
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Overview of Southwest Oncology Group clinical trials in non-Hodgkin lymphomaRichard I Fisher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2004
Mantle cell lymphoma: at last, some hope for successful innovative treatment strategiesRichard I Fisher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Advanced insights into the biology of malignant lymphomasRichard I Fisher
Journal of the National Comprehensive Cancer Network : JNCCN|November 26, 2019
Optimizing First-Line Therapy for Follicular Lymphoma: Is It Time for Chemotherapy-Free Approaches?Richard I Fisher
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Overview of Southwest Oncology Group Clinical Trials in non-Hodgkin Lymphoma. S0016. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + iodine131-labeled monoclonal anti-B1 antibody (tositumomab) for treatment of newly diagnosed follicular NHLRichard I Fisher
Seminars in Hematology|October 10, 2006
Treatment of diffuse large B-cell lymphomasRichard I Fisher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Novel therapeutics for aggressive non-Hodgkin's lymphomaDaruka Mahadevan, Richard I Fisher
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Is observation dead in follicular lymphoma? No, but the apoptosis pathway has been activatedRichard I Fisher, Nadia Khan
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Seminars in Oncology|May 3, 2003
Overview of non-Hodgkin's lymphoma: biology, staging, and treatmentRichard I Fisher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Autologous stem-cell transplantation as a component of initial treatment for poor-risk patients with aggressive non-Hodgkin's lymphoma: resolved issues versus remaining opportunityRichard I Fisher
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Overview of Southwest Oncology Group clinical trials in non-Hodgkin lymphomaRichard I Fisher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2004
Mantle cell lymphoma: at last, some hope for successful innovative treatment strategiesRichard I Fisher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Advanced insights into the biology of malignant lymphomasRichard I Fisher
Journal of the National Comprehensive Cancer Network : JNCCN|November 26, 2019
Optimizing First-Line Therapy for Follicular Lymphoma: Is It Time for Chemotherapy-Free Approaches?Richard I Fisher
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Overview of Southwest Oncology Group Clinical Trials in non-Hodgkin Lymphoma. S0016. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + iodine131-labeled monoclonal anti-B1 antibody (tositumomab) for treatment of newly diagnosed follicular NHLRichard I Fisher
Seminars in Hematology|October 10, 2006
Treatment of diffuse large B-cell lymphomasRichard I Fisher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Novel therapeutics for aggressive non-Hodgkin's lymphomaDaruka Mahadevan, Richard I Fisher
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Is observation dead in follicular lymphoma? No, but the apoptosis pathway has been activatedRichard I Fisher, Nadia Khan
Pageof 14